Skip to content

DIAGNOSTIC SYSTEMS

Active
Public limited companyfounded 198541 yrs activeRue Marcel Louis 42, 1315 Incourt, BelgiumKBO/BCE: BE 0427.059.722
Summary

DIAGNOSTIC SYSTEMS has been active since 1985 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €216,621 and a net result of -€4,112. Equity is shrinking by ~4% per year across the filed fiscal years. Its solvency ranks better than 95% of 5730 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).

Risk analysisWatch ReportCompare
DIAGNOSTIC SYSTEMSActiveChecked score 97/100
Risk analysis ReportCompare

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460NACE 51460
#3 oldest company in Incourt, Wholesale and retail trade sector1 site
Size
€9,150turnover 2025
Equity
€216,621
Loss
-€4,112
Financial health
97 Excellent Checked score 2025
Bankruptcy chance 12 m
< 0.1%
Structure
Accounts filed 25 d late0 of 6 deeds read
Why 97+ Founded in 1985+ Liquidity: current ratio 3.90, cash €69,963+ Equity €216,621 (92.3% of total assets)+ Figures for FY 2025 (filed 25-08-2026)Show the evidence

Checked score

Score 2025
97 / 100
Excellent
Probability in this band: under 0.55%
Better than 74% of its sector peers (NACE 46, micro)
Performance against the sector, not lower risk
Every signal that weighs is under Signals.
Financial strength · tick = 2024
Strong
Solvency 100=
equity 92.3% of total assets
Liquidity 87+4
short-term debt 7.7% · cash 29.8%
Profitability 78=
return on assets -1.8%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (26,775 companies)
Last 24 months 11-2024: < 0.1%lowest value 12-2024: < 0.1%● 0.0% vs 11-2024lowest value 01-2025: < 0.1%● 0.0% vs 12-2024lowest value 02-2025: < 0.1%▲ +2.5% vs 01-2025 03-2025: < 0.1%● 0.0% vs 02-2025 04-2025: < 0.1%▲ +2.4% vs 03-2025 05-2025: < 0.1%● 0.0% vs 04-2025 06-2025: < 0.1%▲ +2.4% vs 05-2025 07-2025: < 0.1%▲ +9.3% vs 06-2025 08-2025: 0.1%▲ +68.1% vs 07-2025 09-2025: 0.1%▲ +25.3% vs 08-2025highest value 10-2025: < 0.1%▼ -59.6% vs 09-2025lowest value 11-2025: < 0.1%● 0.0% vs 10-2025lowest value 12-2025: < 0.1%● 0.0% vs 11-2025lowest value 01-2026: < 0.1%▲ +2.5% vs 12-2025 02-2026: < 0.1%● 0.0% vs 01-2026 03-2026: < 0.1%● 0.0% vs 02-2026 04-2026: < 0.1%▲ +4.9% vs 03-2026 05-2026: < 0.1%● 0.0% vs 04-2026 06-2026: < 0.1%● 0.0% vs 05-2026 07-2026: < 0.1%▲ +4.7% vs 06-2026 08-2026: 0.1%▲ +86.7% vs 07-2026 09-2026: < 0.1%▼ -51.2% vs 08-2026 10-2026: < 0.1%● 0.0% vs 09-2026
  • Founded in 1985 lowers the probability for this profile
  • Liquidity: current ratio 3.90, cash €69,963 lowers the probability
  • Equity €216,621 (92.3% of total assets) lowers the probability
  • Figures for FY 2025 (filed 25-08-2026) lowers the probability
Credit up to €500 at 30 days acceptable
Liquidity ample (current ratio 3.9 against 5.12 in 2024; short-term debt: 7.7% and cash: 29.8% of total assets), and 7.7% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 46, micro). Better than this share of them on solvency 90%, liquidity 87%, profitability 68%, growth against the median 50%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 03-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Founded in 1985
In the bankruptcy model this factor lowers the probability for this profile.
KBO
lowers risk · Liquidity: current ratio 3.90, cash €69,963
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
lowers risk · Equity €216,621 (92.3% of total assets)
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
lowers risk · Figures for FY 2025 (filed 25-08-2026)
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 25-08-2026, 25 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
25 d late
2024
28 d late
2023
16 d late
2022
19 d late
2021
7 d late
2020
3 d late
2019
on the day
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 14 days after the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 19 August (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
03-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · full…
  2. Annual accounts filedfiscal year 2024 · full…
  3. Annual accounts filedfiscal year 2023 · full…

Key points

  • Risk: 4 loss-making years in a rowloss fiscal year 2025 -€4,112 View
  • Positive: Among the best 6% on solvencysector median 45.5% · 5,730 companies 92.3% View
  • Active since 1985founded 28-03-1985 41 years View

By topic

Financials

Fiscal year
2025
Turnover
€9,150
Loss
-€4,112
Solvency
92.3%
Turnover▲ 6.9%
Net result
20182025
Go to Financials

Timeline

Events
14
Since
2017
Next accounts
by 31-07-2027
  1. 25-08-2026Annual accounts filed
  2. 28-08-2025Annual accounts filed
  3. 16-08-2024Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
28-03-1985
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure